Elon Musk’s Ketamine Scandal EXPOSED

Man in suit smiling, resting chin on hand.

Susie Wiles’ candid remarks about Elon Musk’s ketamine use have sparked a political firestorm, questioning the integrity of Trump’s administration.

Story Overview

Susie Wiles labeled Elon Musk as an “avowed ketamine user” and an “odd duck.”
Audio recordings confirm Wiles’ remarks despite initial denials from the White House.
Wiles’ comments intersect with ongoing scrutiny of Musk’s drug use and influence.
The dismantling of USAID by Musk’s task force raises humanitarian concerns.

Wiles’ Controversial Remarks

In a series of interviews with *Vanity Fair*, Susie Wiles, Trump’s Chief of Staff, openly criticized Elon Musk, describing him as an “avowed ketamine user” and an “odd duck” who sleeps in a sleeping bag at the Executive Office Building. These comments emerged during Musk’s leadership of the Department of Government Efficiency (DOGE), where he played a significant role in dismantling USAID. The remarks were initially disputed by Wiles and the White House, but audio recordings later confirmed their accuracy.

The *Vanity Fair* article that published Wiles’ comments triggered a political and media backlash. The White House attempted to discredit the article, claiming some quotes were fabricated. However, the journalist Chris Whipple produced recordings that verified Wiles’ statements, causing further embarrassment for the administration. The remarks have intensified the debate over Musk’s behavior and his impact on government operations.

Implications of Musk’s Role

Musk’s leadership in DOGE, tasked with aggressive cost-cutting, led to the dismantling of over 80% of USAID’s work. This action has drawn criticism from global health officials who warn of catastrophic consequences, including disruptions to HIV/AIDS programs. Wiles expressed her concerns about Musk’s management style and the drastic cuts, describing herself as “aghast” at some decisions. Her candid assessments highlight the tension between Musk’s influence and the traditional governance structures.

Musk has publicly acknowledged using prescription ketamine in small doses for depression, but he denies broader drug use allegations. Despite Musk’s denials, Wiles’ remarks have reinforced a media narrative questioning his drug use and its implications for national security and corporate governance. The controversy has placed additional scrutiny on Musk’s role in the government and his relationship with Trump.

The Fallout and Future Concerns

The confirmation of Wiles’ remarks has damaged the credibility of the White House’s public statements and strained internal relationships. Musk remains a crucial figure in Trump’s agenda, yet the controversy over his alleged drug use and the dismantling of USAID continues to pose challenges. The disbanding of DOGE by late 2025, with unverified claims of $214 billion in cuts, leaves questions about the true impact of Musk’s cost-cutting measures.

The broader narrative surrounding Musk’s influence in the government and his personal behavior remains a contentious issue. As the administration navigates these challenges, the balance between political alliances and effective governance will be closely watched, with potential implications for both domestic and international policies.